Hyperion Therapeutics Inc
HPTX · Chemicals & Drugs · NASDAQ · in our data July 26, 2012 to May 7, 2015 (2.8 years)
The first trading day in our data for Hyperion Therapeutics Inc is July 26, 2012 (its first day in our records, which may be later than its listing and is not its founding). At its peak, on April 21, 2015, the market valued it at $968 million. It left the market when it was bought or merged, last trading at $45.99, -0.3% from its split-adjusted high. Holders got whatever the deal paid, which is not in our price data.
Share prices are adjusted for splits and other share changes, so the high and the last price compare like for like; the peak market value is as it was on the day. The return covers the trading days in our data only: it does not include what holders received, or lost, after the last trade (a merger payout, a bankruptcy), and it does not reach back before 2012. How these numbers are made · Report a data issue.
Play today's Daily DropAlso gone in 2015: Chemicals & Drugs
- Allergan peaked at $72.0 billion
- Pharmacyclics Inc peaked at $20.1 billion
- Sigma-Aldrich peaked at $16.8 billion
- Hospira peaked at $15.6 billion
- Salix Pharmaceuticals Ltd peaked at $11.0 billion
- Synageva Biopharma Corp peaked at $8.9 billion
